Aileron Therapeutics, Inc. (ALRN)

NASDAQ: ALRN · Delayed Price · USD
0.490
-0.003 (-0.55%)
At close: Jan 14, 2022 4:00 PM
0.510
0.020 (4.145%)
After-hours:Jan 14, 2022 7:21 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202020192018201720162015
Selling, General & Admin
9.3312.2913.458.777.895.06
Research & Development
11.1717.6618.4514.2410.287.83
Operating Expenses
20.529.9631.923.0118.1712.89
Operating Income
-20.5-29.96-31.9-23.01-18.17-12.89
Other Expense / Income
0.66-0.59-0.36-0.4-0.05-0.01
Pretax Income
-21.16-29.37-31.55-22.6-18.12-12.88
Net Income
-21.16-29.37-31.55-22.6-18.12-12.88
Preferred Dividends
0000.040.080.07
Net Income Common
-21.16-29.37-31.55-22.65-18.2-12.95
Shares Outstanding (Basic)
352515700
Shares Outstanding (Diluted)
352515700
Shares Change
42.11%66.48%98.01%1632.21%7.23%-
EPS (Basic)
-0.61-1.20-2.14-3.04-42.35-32.31
EPS (Diluted)
-0.61-1.20-2.14-3.04-42.35-32.31
Free Cash Flow Per Share
-0.58-1.08-2.19-2.78-34.94-29.46
EBITDA
-20.99-29.21-31.33-22.48-17.89-12.55
EBIT
-21.16-29.37-31.55-22.6-18.12-12.88
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).